Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time

被引：0
作者：
Jiang, Di Maria [1 ]
Hamilton, Robert J. [2 ]
Hansen, Aaron R. [1 ]
机构：
[1] Univ Toronto, Div Med Oncol & Haematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Div Urol, Dept Surg Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2020年 / 14卷 / 02期
关键词：
PHASE-III; CISPLATIN; IFOSFAMIDE; PACLITAXEL; ETOPOSIDE;
D O I：
10.5489/cuaj.6407
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [41] Preoperative immunochemotherapy versus chemotherapy as first-line treatment for patients with stage I-IIIB small-cell lung cancer
    Zhu, Linhai
    Liu, Jiacong
    Huang, Xuhua
    Hu, Jian
    BMC CANCER, 2025, 25 (01)
  • [42] Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database
    Lorch, Anja
    Bascoul-Mollevi, Caroline
    Kramar, Andrew
    Einhorn, Lawrence
    Necchi, Andrea
    Massard, Christophe
    De Giorgi, Ugo
    Flechon, Aude
    Margolin, Kim
    Lotz, Jean-Pierre
    Germa-Lluch, Jose Ramon
    Powles, Thomas
    Kollmannsberger, Christian
    Beyer, Joerg
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) : 2178 - 2184
  • [43] The safety of current treatment options for advanced esophageal cancer after first-line chemotherapy
    Ikeda, Go
    Yamamoto, Shun
    Kato, Ken
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 55 - 65
  • [44] Combination chemotherapy with paclitaxel and oxaliplatin as first-line treatment in patients with advanced gastric cancer
    Lan, Yan-qin
    Kong, Ling-jun
    Lin, Xiao-yan
    Xu, Qian
    Gao, Xin-yan
    Wu, Ri-ping
    Wang, Xin-li
    Zhong, Dong-ta
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (06) : 1007 - 1015
  • [45] Adding bevacizumab to paclitaxel in the first-line treatment of metastatic breast cancer
    Kevin R. Fox
    Current Oncology Reports, 2009, 11 : 5 - 7
  • [46] Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer
    Baltali, E
    Altundag, MK
    Güler, N
    Özisik, Y
    Firat, D
    Baran, I
    Tekuzman, G
    TUMORI, 2002, 88 (03) : 200 - 203
  • [47] Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
    Chan, A.
    Miles, D. W.
    Pivot, X.
    ANNALS OF ONCOLOGY, 2010, 21 (12) : 2305 - 2315
  • [48] The role of capecitabine in first-line treatment for patients with metastatic breast cancer
    Gelmon, Karen
    Chan, Arlene
    Harbeck, Nadia
    ONCOLOGIST, 2006, 11 : 42 - 51
  • [49] Adding Bevacizumab to Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer
    Fox, Kevin R.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (01) : 5 - 6
  • [50] ETOPOSIDE IN THE TREATMENT OF ELDERLY POOR-PROGNOSIS PATIENTS WITH SMALL-CELL LUNG-CANCER
    CARNEY, DN
    BYRNE, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 34 : S96 - S100
12345